MiR-21 and miR-106a, by inhibiting PTEN, activate the PI3K/AKT/mTOR pathway, which leads to the induction of the proliferative properties of the tumor cell, as well as to the suppression of apoptosis and autophagy. The gene discussed is MTOR; the disease is neoplasm.